Eyetech Pharmaceuticals
Latest round
- Series C
Last raised
- Aug 2001
Total raised
- $109M
Investors
- 6
About Eyetech Pharmaceuticals
Eyetech Pharmaceuticals was founded in 2008 in the United States. The company specializes in developing therapies for retinal diseases and has undergone significant growth since its inception.Eyetech Pharmaceuticals specializes in domain name valuation and acquisition services, providing a streamlined process for customers to obtain prices for domain names within a 24-hour timeframe. They offer a user-friendly platform for clients to submit requests, which are assessed by domain experts.Eyetech Pharmaceuticals generates revenue through transaction-based income from its domain valuation and acquisition services. Clients engage with the company through direct transactions for domain price evaluations, with a structured pricing process based on the complexity and value of the domains.Eyetech Pharmaceuticals is exploring future growth initiatives including the launch of new products tailored to enhance their service offerings. As of the most recent deal date in February 2012, the company is positioned for strategic expansion into new markets, focusing on North America and Europe.
Who invested in Eyetech Pharmaceuticals
6 investors across 1 round
See all investors in Eyetech Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Aug 1, 2001
Amount
$109M
Investors
Questions about Eyetech Pharmaceuticals
Who invested in Eyetech Pharmaceuticals?
Eyetech Pharmaceuticals has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eyetech Pharmaceuticals raised?
Eyetech Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Eyetech Pharmaceuticals last raise money?
Eyetech Pharmaceuticals's most recent round on record is a Series C, in Aug 2001.
What does Eyetech Pharmaceuticals do?
Eyetech Pharmaceuticals was founded in 2008 in the United States.
Where is Eyetech Pharmaceuticals headquartered?
Eyetech Pharmaceuticals is headquartered in US.
Which VCs invest in companies like Eyetech Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Eyetech Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Eyetech Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.